论文部分内容阅读
目的:检测D二聚体在体内的增高,并探讨其与冠状动脉损伤及预后的关系。方法:选取86例川崎病(KD)患儿作为观察组无冠状动脉损伤(NCAL)61例,有冠状动脉损伤(CAL)25例;60例健康儿童作为对照组,采用快速免疫分析试验(胶体金方法)检测血浆中D二聚体浓度。结果:D二聚体含量在冠脉损伤组及无冠脉损伤组与对照组比较差异均有统计学意义(P<0.01),在冠脉损伤组与无冠脉损伤组急性期及恢复期比较差异有统计学意义(P<0.05)。结论:D二聚体在川崎病的发生发展中可能起重要作用,D二聚体检测可能对判断病变程度及预后判断有重要帮助。与临床常用的血沉、血小板及CRP比较更有利于病情预后的评估。
OBJECTIVE: To detect the increase of D-dimer in vivo and to explore its relationship with coronary artery injury and prognosis. Methods: Sixty-six children with Kawasaki disease (KD) were selected as the observation group without coronary artery injury (NCAL), 61 with coronary artery injury (CAL), and 60 healthy children as the control group. The rapid immunoassay Gold method) to detect plasma D dimer concentration. Results: There was significant difference in the content of D dimer between the coronary artery injury group and the non-coronary artery injury group and the control group (P <0.01). In the acute and convalescent stage of coronary artery injury group and non-coronary artery injury group, The difference was statistically significant (P <0.05). Conclusion: D dimer may play an important role in the occurrence and development of Kawasaki disease. The detection of D dimer may be helpful to judge the degree of disease and prognosis. Compared with commonly used clinical ESR, platelets and CRP is more conducive to the assessment of the prognosis.